Group items matching

in title, tags, annotations or url

As stated by Alastair Harris-Cartwright "Dr. Andrei Yudin, Professor, Department of Chemistry, University of Toronto, has developed a new and effective process that makes linear peptides circular, which allows these molecules, called macrocycles, to enter cells more effectively and increase their stability compared to linear peptides." The Ontario Genomics Institute (OGI) a MaRS Tenant has invested in this project. The project is also supported by MaRS Innovation that is assisting to convert this "great science into commercial opportunities."

The Ontario Genomics Institute (OGI) teamed up with Invitrogen Corporation, a California-based global leader in providing life sciences technology, recently to host Genome 2.0: New Frontiers in Epigenomics, a one-day symposium addressing epigenetic regulation of gene expression with a special focus on chromatin biology, DNA methylation, non-coding RNAs and technology development.

The Ontario Genomics Institute has given funding to MaRS life sciences client, ArcticDX. They'll use the money for studies in preparation for a Food and Drug Administration approval for their product. The funding comes through its Pre-Commercialization Business Development Fund (PBDF)

TCAG, based at The Hospital for Sick Children, located at the MaRS Centre has provided world-leading infrastructure support to over 1,600 labs worldwide. TCAG has received $5 million in funding.